Holders · period archive

Bellevue Life Sciences Acquisition Corp.

Q1 2023 13F holders among managers we track latest ownership dossier

Type: Equity
Class: COMMON STOCK
Total reported value ($000, long equity)

Manager	Report date	Value	Shares